Clear Street’s Filana Therapeutics FLNA Stock Holding History

Clear Street’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-100	Closed	-$1.24K	–	749
2024 Q2	$1.24K	Buy	+100	New	+$2.11K	﹤0.01%	641

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCM

Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Clear Street's FLNA Position: Q3 2024 in Review

Clear Street sold out of Filana Therapeutics (FLNA) in Q3 2024, closing a stake of 100 shares — an estimated $1.24K sold.

Clear Street first reported a position in FLNA in Q2 2024 and held it in 1 quarter. The position peaked at $1.24K in Q2 2024. 161 funds tracked by Wall St. Rank hold FLNA as of Q3 2024.

Clear Street reported no remaining Filana Therapeutics position as of Q3 2024 after selling out during the quarter.
Clear Street sold 100 Filana Therapeutics shares in Q3 2024, an estimated $1.24K.
Clear Street first reported a position in Filana Therapeutics in Q2 2024 and held it in 1 quarter.
Clear Street's Filana Therapeutics position peaked at $1.24K in Q2 2024.
161 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2024.

Based on Clear Street's 13F filing for Q3 2024, filed 14 Nov 2024.